GLUCAGEN Side Effects

6499027-8 | Device Malfunction, Hypoglycaemic Seizure, Hypoglycaemic Unconsciousness
on Oct 13, 2008 Male patient from UNITED STATES , child 9 years of age, weighting 127.2 lb, was diagnosed with hypoglycaemia, type 1 diabetes mellitus and was treated with Glucagen (View Usage). Patient experienced the following unwanted or unexpected effects: device malfunction, hypoglycaemic seizure, hypoglycaemic unconsciousness. Glucagen dosage: . During the same period patient was treated with NOVOLOG (Subcutan.-pump) (View Novolog Review and Novolog Label ).

6156720-4 | Device Malfunction, Hypoglycaemic Seizure, Hypoglycaemic Unconsciousness
Patient was taking Glucagen (View Usage). Patient had the following side effects: device malfunction, hypoglycaemic seizure, hypoglycaemic unconsciousness on Oct 13, 2008 from UNITED STATES Additional patient health information: Male patient , child 9 years of age, weighting 127.2 lb, was diagnosed with hypoglycaemia, type 1 diabetes mellitus and. Glucagen dosage: . During the same period patient was treated with NOVOLOG (Subcutan.-pump) (View Novolog Review and Novolog Label ).

6083875-2 | Device Malfunction, Hypoglycaemic Seizure, Hypoglycaemic Unconsciousness
Adverse event was reported on Oct 13, 2008 by a Male patient taking Glucagen (View Usage) (Dosage: ) was diagnosed with hypoglycaemia, type 1 diabetes mellitus and. Location: UNITED STATES , child 9 years of age, weighting 127.2 lb, After Glucagen was administered, patient had the following side effects: device malfunction, hypoglycaemic seizure, hypoglycaemic unconsciousness. During the same period patient was treated with NOVOLOG (Subcutan.-pump) (View Novolog Review and Novolog Label ).

6064160-1 | Hypotension, Syncope
on Jan 28, 2009 Male patient from FRANCE , 29 years of age, weighting 233.7 lb, was diagnosed with glucagon tolerance test and was treated with Glucagen (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, syncope. Glucagen dosage: 1 Unk, Unk. Patient was hospitalized.


6048768-5 | Hypertension, Syncope
on Jan 15, 2009 Male patient from FRANCE , 29 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glucagen (View Usage). Patient had the following side effects: hypertension, syncope. Glucagen dosage: 1 Unk, Unk. Patient was hospitalized.

6018090-1 | Anaemia, Hepatic Function Abnormal, Jaundice Cholestatic
Patient was taking Glucagen (View Usage). After Glucagen was administered, patient had the following side effects: anaemia, hepatic function abnormal, jaundice cholestatic on Dec 18, 2008 from JAPAN Additional patient health information: Male patient , weighting 5.29 lb, was diagnosed with hypoglycaemia and. Glucagen dosage: 6.5ug/kg/hr. Patient was hospitalized.

5672126-6 | Anaemia, Hepatic Function Abnormal, Jaundice Cholestatic
Adverse event was reported on Mar 11, 2008 by a Male patient taking Glucagen (View Usage) (Dosage: 6.5ug/kg/hr) was diagnosed with hypoglycaemia and. Location: JAPAN , weighting 5.29 lb, Patient experienced the following unwanted or unexpected effects: anaemia, hepatic function abnormal, jaundice cholestatic. Patient was hospitalized.

5650494-9 | Anaemia, Hepatic Function Abnormal, Jaundice Cholestatic
on Feb 23, 2008 Male patient from JAPAN , weighting 5.29 lb, was diagnosed with hypoglycaemia and was treated with Glucagen (View Usage). Patient had the following side effects: anaemia, hepatic function abnormal, jaundice cholestatic. Glucagen dosage: 6.5ug/kg/hr. Patient was hospitalized.

5619847-9 | Hepatic Function Abnormal, Jaundice Cholestatic
on Jan 29, 2008 Male patient from JAPAN , weighting 5.29 lb, was treated with Glucagen (View Usage). After Glucagen was administered, patient had the following side effects: hepatic function abnormal, jaundice cholestatic. Glucagen dosage: 43 Pg/kg/hr, Qd. Patient was hospitalized.

5607559-7 | Cold Sweat, Dyspnoea, Feeling Hot
Patient was taking Glucagen (View Usage). Patient experienced the following unwanted or unexpected effects: cold sweat, dyspnoea, feeling hot on Jan 24, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 61 years of age, was diagnosed with muscle spasms and. Glucagen dosage: 1 Mg, Qd. Patient was hospitalized.

5607492-0 | Cold Sweat, Dyspnoea, Feeling Hot, Panic Reaction
Adverse event was reported on Jan 24, 2008 by a Male patient taking Glucagen (View Usage) (Dosage: 1 Mg, Qd) was diagnosed with muscle spasms and. Location: UNITED KINGDOM , 77 years of age, Patient had the following side effects: cold sweat, dyspnoea, feeling hot, panic reaction. Patient was hospitalized.

5562784-9 | Device Failure, Injection Site Vesicles
on Dec 06, 2007 Male patient from FRANCE , 64 years of age, was treated with Glucagen (View Usage). After Glucagen was administered, patient had the following side effects: device failure, injection site vesicles. Glucagen dosage: . During the same period patient was treated with NOVORAPID (View Novorapid Review and Novorapid Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

5528772-3 | Device Failure, Injection Site Vesicles
on Nov 20, 2007 Male patient from FRANCE , 64 years of age, was treated with Glucagen (View Usage). Patient experienced the following unwanted or unexpected effects: device failure, injection site vesicles. Glucagen dosage: . During the same period patient was treated with NOVORAPID (View Novorapid Review and Novorapid Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

5498690-8 | Device Failure, Injection Site Vesicles
Patient was taking Glucagen (View Usage). Patient had the following side effects: device failure, injection site vesicles on Oct 16, 2007 from FRANCE Additional patient health information: Male patient , 64 years of age, . Glucagen dosage: . During the same period patient was treated with NOVORAPID (View Novorapid Review and Novorapid Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

5296244-X | Condition Aggravated, Multi-organ Failure, Phaeochromocytoma
Adverse event was reported on Apr 02, 2007 by a Male patient taking Glucagen (View Usage) (Dosage: 1 Mg, Qd) was diagnosed with diabetes mellitus non-insulin-dependent, hypertension and. Location: NETHERLANDS , 45 years of age, After Glucagen was administered, patient had the following side effects: condition aggravated, multi-organ failure, phaeochromocytoma. During the same period patient was treated with GLIMEPIRIDE (2 Mg, Qd) (View Glimepiride Review and Glimepiride Label ), METOPROLOL SUCCINATE (50 Mg, Qd) (View Metoprolol Succinate Review and Metoprolol Succinate Label ). Patient was hospitalized.

5272254-3 | Condition Aggravated, Multi-organ Failure, Phaeochromocytoma
on Mar 09, 2007 Male patient from NETHERLANDS , 45 years of age, was diagnosed with diabetes mellitus non-insulin-dependent, hypertension and was treated with Glucagen (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, multi-organ failure, phaeochromocytoma. Glucagen dosage: 1 Mg, Qd. During the same period patient was treated with GLIMEPIRIDE (2 Mg, Qd) (View Glimepiride Review and Glimepiride Label ), METOPROLOL SUCCINATE (50 Mg, Qd) (View Metoprolol Succinate Review and Metoprolol Succinate Label ). Patient was hospitalized.

5103725-8 | Depressed Level Of Consciousness, Headache
on Jul 10, 2006 Female patient from FRANCE , 60 years of age, weighting 222.7 lb, was diagnosed with glucagon tolerance test and was treated with Glucagen (View Usage). Patient had the following side effects: depressed level of consciousness, headache (What is headache?). Glucagen dosage: 1 Mg, Single. During the same period patient was treated with STAGID (700 Mg, Qd) (View Stagid Review and Stagid Label ).

5061348-3 | Nausea, Palpitations
Patient was taking Glucagen (View Usage). After Glucagen was administered, patient had the following side effects: nausea (What is nausea?), palpitations on Jun 26, 2006 from FRANCE Additional patient health information: Male patient , 53 years of age, weighting 295.4 lb, was diagnosed with glucagon tolerance test and. Glucagen dosage: 1 Mg, Unk. Patient was hospitalized.

5058449-2 | Depressed Level Of Consciousness, Headache
Adverse event was reported on Jul 10, 2006 by a Female patient taking Glucagen (View Usage) (Dosage: 1 Mg, Single) was diagnosed with glucagon tolerance test and. Location: FRANCE , 60 years of age, weighting 222.7 lb, Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, headache (What is headache?). During the same period patient was treated with STAGID (700 Mg, Qd) (View Stagid Review and Stagid Label ).

5058446-7 | Cardiac Arrest, Convulsion
on Jun 26, 2006 Male patient from FRANCE , 41 years of age, weighting 154.3 lb, was diagnosed with glucagon tolerance test, diabetes mellitus insulin-dependent and was treated with Glucagen (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), convulsion. Glucagen dosage: 1 Mg, Unk. During the same period patient was treated with LANTUS (4 Iu, Unk) (View Lantus Review and Lantus Label ).

5058444-3 | Headache, Hyperhidrosis, Loss Of Consciousness
on Jun 26, 2006 Male patient from FRANCE , 43 years of age, weighting 183.0 lb, was diagnosed with glucose tolerance test, diabetes mellitus non-insulin-dependent and was treated with Glucagen (View Usage). After Glucagen was administered, patient had the following side effects: headache (What is headache?), hyperhidrosis, loss of consciousness. Glucagen dosage: 1 Mg, Single. During the same period patient was treated with DIAMICRON (View Diamicron Review and Diamicron Label ), METFORMIN (View Metformin Review and Metformin Label ), ASPERGIC (160 Mg, Unk) (View Aspergic Review and Aspergic Label ).

5045425-9 | Cardiac Arrest, Convulsion
Patient was taking Glucagen (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), convulsion on Jun 26, 2006 from FRANCE Additional patient health information: Male patient , 41 years of age, weighting 154.3 lb, was diagnosed with glucagon tolerance test, diabetes mellitus insulin-dependent and. Glucagen dosage: 1 Mg, Unk. During the same period patient was treated with LANTUS (4 Iu, Unk) (View Lantus Review and Lantus Label ).

4572454-1 | Cardiac Arrest, Circulatory Collapse, Feeling Abnormal, Ventricular Fibrillation
Adverse event was reported on Jan 25, 2005 by a Female patient taking Glucagen (View Usage) (Dosage: ) was diagnosed with hypoglycaemia and. Location: , 72 years of age, weighting 154.3 lb, Patient had the following side effects: cardiac arrest (What is cardiac arrest?), circulatory collapse, feeling abnormal, ventricular fibrillation. During the same period patient was treated with ATORVASTATIN (80 Mg, Qd) (View Atorvastatin Review and Atorvastatin Label ), CLOPIDOGREL (75 Mg, Qd) (View Clopidogrel Review and Clopidogrel Label ), ISOSORBIDE (60 Mg, Unk) (View Isosorbide Review and Isosorbide Label ), METFORMIN HCL (850 Mg, Bid) (View Metformin Hcl Review and Metformin Hcl Label ), DOXAZOSIN (2 Mg, Bid) (View Doxazosin Review and Doxazosin Label ), ASPIRIN (150 Mg, Qd) (View Aspirin Review and Aspirin Label ), ENALAPRIL MALEATE (10 Mg, Bid) (View Enalapril Maleate Review and Enalapril Maleate Label ), DILTIAZEM (90 Mg, Bid) (View Diltiazem Review and Diltiazem Label ).